Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Alexion agreement targets mitochondrial disease

Alexion and Stealth BioTherapeutics Corp have agreed to co-develop and commercialize elamipretide for mitochondrial diseases. Currently being evaluated in a Phase 3 study in people...

| By Kelley Gipson

Alexion to acquire Achillion

Alexion and Achillion have announced that they have entered into a definitive agreement for Alexion to acquire Achillion. Achillion is a clinical-stage biopharmaceutical company focused...

| By Kelley Gipson

Jackson Laboratory receives funding re eyes, aging

The National Eye Institute has continued funding for The Jackson Laboratory‘s Eye Mutant Resource. Serious or disabling eye diseases affect many millions of people worldwide...

| By Kelley Gipson

UConn developing system for treating depression

University of Connecticut professor of computer science and engineering Bing Wang is the lead principal investigator on a new $1 million grant from the National...

| By Kelley Gipson

VentureClash finalists named for 10/17 showdown

Connecticut Innovations, Connecticut’s strategic venture capital arm, has announced the finalists for VentureClash, the $5 million global venture challenge. The 10 finalists will participate in a...

| By Kelley Gipson

Biohaven migraine treatment wins priority review

Biohaven said in a recent regulatory filing that the FDA has accepted its new drug application for treatment and prevention of migraine headaches. The filing...

| By Kelley Gipson

BioCT welcomes new member Insperity

Insperity, a small business consultant for more than 30 years, provides an array of human resource solutions designed to restructure operations and streamline performance. Insperity...

| By Kelley Gipson

Vanessa acquires Hungaro-Gal re Shylicine®

Vanessa Research (VRI) has acquired Hungaro-Gal, a Hungarian pharmaceutical contract manufacturing company. Per the acquisition, VRI will continue Hungaro-Gal’s contract manufacturing services and intends to maintain...

| By Kelley Gipson

Arvinas adds oncology, neurology experts to SAB

Arvinas has announced that six new thought leaders will join the company’s scientific advisory board. The new members are Tomasz M. Beer, M.D., F.A.C.P., Adam L....

| By Kelley Gipson

The microbiome and the nursing home

JAX and UConn researchers are exploring how patients’ microbiome, and risk of infection, change after time in a skilled nursing facility. A $778,801 grant from the National...